This bill establishes THC potency limits for various cannabis products, including cannabis flower, concentrates, and topical or transdermal products. Specifically, it mandates that cannabis flower sold in the adult-use market must not exceed 15% total THC, while cannabis concentrates are limited to 30% total THC. Additionally, topical or transdermal cannabis and hemp products must not contain more than 500 milligrams of total THC per package. The bill also prohibits the sale of cannabis flower or prerolls infused with additional THC or psychoactive cannabinoids.

Furthermore, the bill requires cannabis businesses to post warning notices at retail locations and include specific warning statements on product labels. These warnings address potential health risks associated with cannabis use, particularly for individuals under 25, and emphasize the dangers of cannabis poisoning, especially for children. The labeling requirements are extensive, mandating information such as the product's cannabinoid profile, usage instructions, and verification of testing compliance. The bill amends several sections of Minnesota Statutes to incorporate these new regulations and definitions, enhancing consumer safety and awareness regarding cannabis products.

Statutes affected:
Introduction: 342.01, 342.06, 342.27